October 19-22, 2020
Now Delivered 100% Virtually,
in Eastern Standard Time (EST)
The cell and gene therapy event for ground breaking bioprocessing, manufacturing & supply chain strategies
World renowned leaders share the latest analytical techniques & vector technologies to revolutionize your cell, gene & gene edited ex vivo cell therapy programs
Introduction Video
by Sarah Lintern
Conference Director, Cell & Gene Therapy Portfolio
Interested in speaking opportunities? Or, if you have any questions about the event, please reach out directly:
REDEFINING YOUR LEARNING EXPERIENCE
In light of the current global climate, it is more important than ever for the cell & gene therapy community to connect with one another, strategize and share ideas – All in a safe, responsible way. With our dedication to address the most pressing issues, our cell and gene therapy events, now taking place October 19 - 22, have undergone a timely transformation, moving to an all-digital format and offering attendees the ability to participate in virtual content, exhibits and networking opportunities.
UNIQUE BENEFITS OF THIS ALL-VIRTUAL EVENT:
UNIQUE BENEFITS OF THIS ALL-VIRTUAL EVENT:
• Customizable agenda with access to expanded session offerings
• Convenient session scheduling for increased productivity
• On-demand access to content and topic resources
• Interactive presentations/panels for reinforced learning
• Pointed problem-solving and solution sourcing
• Broader industry benchmarking and post-event analytics/insights
• Elevated and direct access to thought leaders and experts
POWER OF NETWORKING:
POWER OF NETWORKING:
Who’s Who?
Attendee and company profiles provide insight into the delegation and sponsoring organizations
Advanced search capabilities to identify opportunities and potential partners
When and How to Connect?
Sophisticated and seamless scheduling tools to establish meeting times
Ease-of-use technology to enable virtual networking
DIGITAL CAPABILITIES AND FEATURES:
DIGITAL CAPABILITIES AND FEATURES:
• Access to Virtual Environment
• Audience Q&A
• Live Polling
• Expert-Led Problem-Solving
• Virtual Networking and Partnering
COMPREHENSIVE CONTENT AND DYNAMIC FEATURES:
COMPREHENSIVE CONTENT AND DYNAMIC FEATURES:
• 4 Days of Live Keynotes
• 25+ On-Demand Sessions
• Over 8 Hours of Live Speaker Q&A and Interactive Roundtables
• Networking with Industry Colleagues and Counterparts
Why Choose Cell & Gene Therapy Bioprocessing & Commercialization Virtual?
Our Cell & Gene Therapy Virtual Conference & Exhibition is not just another webinar or zoom call.
Watch our highlight video and see why the global cell therapy industry chooses our event ground breaking bioprocessing, manufacturing & supply chain strategies.
CRITICAL CELL & GENE THERAPY INSIGHTS FROM 70+ EXPERTS DURING A TIME OF TRANSFORMATIVE CHANGE, FEATURING:
IN-DEPTH ON-DEMAND CONTENT — WHAT YOU WANT. WHEN YOU WANT IT
Access all of the extensively researched agenda and sessions with the novelty of being able to view it at your own pace. How? All presentations will be made available both live and on-demand for 30 days, so you will be able to attend more presentations than ever before! Have 2 live sessions that you want to attend at the same time? Now you can watch one live and watch the other on-demand at a time that suits you.
Adherent Cell Manufacturing & Process Development
Lior Raviv, Vice President Development & Operations, Pluristem Therapeutics Inc., Israel
Will Allogeneic Cell Therapies Replace the Current Autologous Models?
Geoffrey Hodge, formerly, Chief Technical Officer, Unum Therapeutics Inc., USA
Development of Modern Biologics and Cell Therapy Products Through Global CMOs
Vadim Klyushnichenko, VP Pharmaceutical Development & Quality, Calibr & Scripps Research, USA
Assessing the Future Prospects of Upstream Bioprocessing Systems for Commercial AAV Production
Scott Jeffers, Director, UniQure, USA
Raw Materials: BOMs, Risks & Securing Supply
Tom Walls, Associate Director Supply Chain, bluebird bio, USA
Sourcing Appropriate Starting and Ancillary Materials for Manufacturing Cell and Gene Therapy Products
Kathy Williams, VP Quality & Reg Affairs, RoosterBio Inc., USA
Pathogen Safety Margins for Gene Therapy Manufacturing
Thomas R. Kreil, VP, Global Head Pathogen Safety, Takeda Inc., Austria
Exposing the Content of Different AAV Fractions after Ultracentrifugation
David Dobnik, Senior Research Associate, National Institute of Biology, Slovenia
The Case for rAAV Titration by HPLC
Franz Schnetzinger, Director Quality Control & CMC Analytical Development, Gyroscope Therapeutics Limited, UK
AI in Cell and Gene Therapy Manufacturing
Michael Roberts, Chief Technology Officer (Europe), Asklepios
BioPharmaceutical, Inc., UK
Potency & Fully Characterizing your Cell Product
Amandine Breton, Cell Therapy Operations Manager, Orchard Therapeutics, UK (pending final confirmation)
Product Dependent Cryopreservation Protocols
David McKenna, Professor and American Red Cross Chair in Transfusion Medicine, Department of Laboratory Medicine and Pathology, University of Minnesota, USA
Fresh vs. Cryopreserved: Tightening up Supply Chains
Jason Acker, Professor, Laboratory Medicine and Pathology, University of Alberta, Canada
Implementation of “off the shelf” Closed Systems fit for every purpose
Ali Mohamed, VP, CMC, Immatics, USA
Re- Dosing: Is Gene Therapy Really a Cure?
Kei Kishimoto, Chief Scientific Officer, Selecta Biosciences, USA
Poster Presentation
Consider presenting a poster at this virtual event to derive more value from attending. Share your research with your peers and learn from other posters as well. Many attendees tell us that being selected for a poster presentation helps to facilitate their company approval process to attend the event. Submit your poster abstract online today using the form below.
Deadline: 4th September 2020
CONNECT WITH KEY BUYERS AT Cell & Gene Therapy 2020 VIRTUALLY
Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.
(Companies A-L) Contact Kristin Skahan: Kristin.Skahan@informa.com | +1-857-504-6730
(Companies M-Z) Contact Perri Lucatello: Perri.Lucatello@informa.com | +44 (0)20 7017 7247
